CTSO · CytoSorbents Corp
The AI's read
Lower costs and a wider product margin helped shrink operating losses. That points to better control of spending, even though sales grew only slightly. The company had $5.7 million in cash, and its nine-month reported loss rose to $12.0 million from $2.7 million. The company said currency results drove that increase. Better quarterly operations and positive operating cash flow outweigh those concerns.